Crossmark Global Holdings Inc. grew its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 6.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,077 shares of the company’s stock after buying an additional 440 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Acadia Healthcare were worth $449,000 at the end of the most recent quarter.
Several other institutional investors have also made changes to their positions in ACHC. GAMMA Investing LLC grew its position in Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after purchasing an additional 241 shares in the last quarter. Blue Trust Inc. lifted its stake in Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after acquiring an additional 248 shares in the last quarter. Commonwealth Equity Services LLC grew its stake in Acadia Healthcare by 3.5% during the 2nd quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock valued at $513,000 after acquiring an additional 257 shares in the last quarter. Atria Investments Inc increased its holdings in shares of Acadia Healthcare by 4.7% in the 3rd quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock valued at $434,000 after purchasing an additional 308 shares during the period. Finally, Arizona State Retirement System lifted its position in shares of Acadia Healthcare by 2.1% in the second quarter. Arizona State Retirement System now owns 25,874 shares of the company’s stock worth $1,748,000 after purchasing an additional 531 shares in the last quarter.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on ACHC shares. KeyCorp started coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a research note on Tuesday, October 1st. Royal Bank of Canada restated an “outperform” rating and issued a $94.00 target price on shares of Acadia Healthcare in a research note on Friday, September 20th. StockNews.com raised Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Thursday. Finally, Barclays lowered their price target on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research note on Monday, September 30th. Five analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $86.67.
Acadia Healthcare Stock Down 3.9 %
Shares of Acadia Healthcare stock opened at $37.82 on Friday. Acadia Healthcare Company, Inc. has a 12-month low of $37.78 and a 12-month high of $87.77. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock has a 50 day moving average price of $58.05 and a two-hundred day moving average price of $65.60. The stock has a market capitalization of $3.51 billion, a P/E ratio of 12.40, a PEG ratio of 1.76 and a beta of 1.33.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. During the same quarter last year, the firm posted $0.91 EPS. The business’s quarterly revenue was up 8.7% on a year-over-year basis. Equities analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Stories
- Five stocks we like better than Acadia Healthcare
- Where Do I Find 52-Week Highs and Lows?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- What Investors Need to Know About Upcoming IPOs
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Short Selling: How to Short a Stock
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.